Gain Therapeutics (GANX) Institutional Ownership $1.80 +0.06 (+3.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.80 0.00 (0.00%) As of 04/17/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)CurrentInstitutional OwnershipPercentage11.97%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$1.25MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$390.93K Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GANX Institutional Buying and Selling by Quarter Gain Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Gotham Asset Management LLC158,155$342K0.0%-52.7%0.596% 2/17/2025Bridgeway Capital Management LLC30,004$65K0.0%N/A0.113% 2/14/2025Northern Trust Corp84,586$183K0.0%+88.2%0.319% 2/13/2025Marshall Wace LLP91,738$198K0.0%N/A0.346% 2/12/2025Geode Capital Management LLC267,421$578K0.0%-1.7%1.008% 2/6/2025Jones Financial Companies Lllp98,250$212K0.0%+83.6%0.370% 2/4/2025Sprott Inc.14,000$30K0.0%N/A0.053% 1/28/2025Benedict Financial Advisors Inc.16,000$35K0.0%N/A0.060% 11/16/2024Geode Capital Management LLC271,972$484K0.0%+48.0%1.065% 8/9/2024Renaissance Technologies LLC118,700$152K0.0%+154.2%0.658% Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2024Warberg Asset Management LLC51,600$66K0.0%N/A0.286% 8/3/2024Hohimer Wealth Management LLC330,000$422K0.1%N/A1.828% 1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184% 7/25/2023Raymond James & Associates33,400$150K0.0%+67.0%0.271% 5/8/2023CM Management LLC90,000$434K0.5%-18.2%0.740% 5/2/2023 Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105% 4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168% 2/9/2023CM Management LLC110,000$344K0.4%-12.0%0.926% 1/17/2023 Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158% 11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263% 10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202% 10/12/2022 Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210% 5/9/2022CM Management LLC125,000$511K0.4%+38.9%1.052% 2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085% 2/2/2022CM Management LLC90,000$489K0.4%+39.9%0.758% 11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810% 11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211% 11/9/2021Indie Asset Partners LLC29,652$221K0.2%N/A0.250% 11/8/2021CM Management LLC64,327$479K0.4%+543.3%0.542% 8/17/2021Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421% 8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255% 8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025% 8/10/2021CM Management LLC10,000$100K0.1%N/A0.084% 5/27/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/19/2021Worth Venture Partners LLC15,532$232K0.1%N/A0.131% 5/18/2021Millennium Management LLC14,367$214K0.0%N/A0.121% 5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602% 5/18/2021Davidson Kempner Capital Management LP15,000$222K0.0%N/A0.126% 5/18/2021Jane Street Group LLC22,754$339K0.0%N/A0.192% (Data available from 1/1/2016 forward) GANX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GANX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Gain Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($578K), CM Management LLC ($434K), Hohimer Wealth Management LLC ($422K), Gotham Asset Management LLC ($342K), Jones Financial Companies Lllp ($212K), Marshall Wace LLP ($198K), and Northern Trust Corp ($183K).Learn more on GANX's institutional investors. What percentage of Gain Therapeutics stock is owned by institutional investors? 11.97% of Gain Therapeutics stock is owned by institutional investors. Learn more on GANX's institutional investor holdings. Which institutional investors have been buying Gain Therapeutics stock? Of the 11 institutional investors that purchased Gain Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hohimer Wealth Management LLC ($330K), Marshall Wace LLP ($91.74K), Geode Capital Management LLC ($88.24K), Renaissance Technologies LLC ($72K), Warberg Asset Management LLC ($51.60K), Jones Financial Companies Lllp ($44.75K), and Northern Trust Corp ($39.64K). How much institutional buying is happening at Gain Therapeutics? Institutional investors have bought a total of 791,370 shares in the last 24 months. This purchase volume represents approximately $1.31M in transactions. Which Gain Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Gain Therapeutics stock in the last 24 months: Gotham Asset Management LLC ($176.44K), CM Management LLC ($20K), Raymond James & Associates ($10.01K), Wealth Alliance Advisory Group LLC ($6.25K), and Geode Capital Management LLC ($4.55K). How much institutional selling is happening at Gain Therapeutics? Institutional investors have sold a total of 217,249 shares in the last 24 months. This volume of shares sold represents approximately $550.14K in transactions. Related Companies Corvus Pharmaceuticals Major Shareholders CARGO Therapeutics Major Shareholders Cidara Therapeutics Major Shareholders enGene Major Shareholders Foghorn Therapeutics Major Shareholders Esperion Therapeutics Major Shareholders Ocugen Major Shareholders Amarin Major Shareholders biote Major Shareholders SOPHiA GENETICS Major Shareholders This page (NASDAQ:GANX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gain Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.